Continue to site >
Trending ETFs

Name

As of 11/22/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$20.42

$4.89 B

0.63%

$0.13

0.66%

Vitals

YTD Return

14.9%

1 yr return

37.4%

3 Yr Avg Return

1.5%

5 Yr Avg Return

7.0%

Net Assets

$4.89 B

Holdings in Top 10

53.2%

52 WEEK LOW AND HIGH

$20.0
N/A
N/A

Expenses

OPERATING FEES

Expense Ratio 0.66%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 46.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

$0

IRA

N/A


Fund Classification

Fund Type

Open End Mutual Fund


Name

As of 11/22/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$20.42

$4.89 B

0.63%

$0.13

0.66%

FBIOX - Profile

Distributions

  • YTD Total Return 14.9%
  • 3 Yr Annualized Total Return 1.5%
  • 5 Yr Annualized Total Return 7.0%
  • Capital Gain Distribution Frequency Semi-Annually
  • Net Income Ratio -0.14%
DIVIDENDS
  • Dividend Yield 0.6%
  • Dividend Distribution Frequency SemiAnnual

Fund Details

  • Legal Name
    Biotechnology Portfolio
  • Fund Family Name
    Fidelity Investments
  • Inception Date
    Jan 03, 1994
  • Shares Outstanding
    N/A
  • Share Class
    Other
  • Currency
    USD
  • Domiciled Country
    US
  • Manager
    Rajiv Kaul

Fund Description

Normally investing primarily in common stocks. Normally investing at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. Investing in domestic and foreign issuers. Using fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments.
Read More

FBIOX - Performance

Return Ranking - Trailing

Period FBIOX Return Category Return Low Category Return High Rank in Category (%)
YTD 14.9% -27.4% 19.9% 7.55%
1 Yr 37.4% -13.7% 48.1% 5.03%
3 Yr 1.5%* -28.0% 9.5% 51.32%
5 Yr 7.0%* -7.8% 12.2% 64.38%
10 Yr 6.3%* 0.2% 13.1% 72.97%

* Annualized

Return Ranking - Calendar

Period FBIOX Return Category Return Low Category Return High Rank in Category (%)
2023 9.5% -12.6% 19.0% 11.32%
2022 -15.9% -53.9% 3.2% 76.32%
2021 -23.2% -39.6% 24.2% 90.13%
2020 14.0% -13.6% 178.2% 51.01%
2019 24.5% 3.8% 63.8% 27.07%

Total Return Ranking - Trailing

Period FBIOX Return Category Return Low Category Return High Rank in Category (%)
YTD 14.9% -27.4% 19.9% 7.55%
1 Yr 37.4% -13.7% 48.1% 5.03%
3 Yr 1.5%* -28.0% 9.5% 51.32%
5 Yr 7.0%* -7.8% 12.2% 64.38%
10 Yr 6.3%* 0.2% 13.1% 72.97%

* Annualized

Total Return Ranking - Calendar

Period FBIOX Return Category Return Low Category Return High Rank in Category (%)
2023 10.1% -12.6% 19.0% 16.35%
2022 -15.9% -53.9% 3.7% 80.92%
2021 -12.4% -33.9% 26.0% 90.13%
2020 38.3% -0.7% 180.6% 12.75%
2019 36.0% 4.6% 63.8% 6.02%

NAV & Total Return History


FBIOX - Holdings

Concentration Analysis

FBIOX Category Low Category High FBIOX % Rank
Net Assets 4.89 B 6.66 M 45.7 B 16.35%
Number of Holdings 199 25 430 5.66%
Net Assets in Top 10 2.66 B 2.12 M 22.1 B 11.32%
Weighting of Top 10 53.17% 18.4% 79.7% 28.93%

Top 10 Holdings

  1. ABBVIE INC 11.43%
  2. AMGEN INC 9.05%
  3. KRYSTAL BIOTECH INC 7.31%
  4. Fidelity Securities Lending Cash Central Fund 5.58%
  5. REGENERON PHARMACEUTICALS INC 5.20%
  6. VERTEX PHARMACEUTICALS INC 4.41%
  7. ALNYLAM PHARMACEUTICALS INC 3.63%
  8. GILEAD SCIENCES INC 2.61%
  9. UCB SA 1.97%
  10. ZEALAND PHARMA A/S 1.97%

Asset Allocation

Weighting Return Low Return High FBIOX % Rank
Stocks
98.81% 87.34% 106.13% 35.22%
Cash
5.84% 0.00% 33.01% 15.09%
Preferred Stocks
1.03% 0.00% 7.86% 20.75%
Other
0.00% -22.99% 23.24% 85.53%
Convertible Bonds
0.00% 0.00% 0.37% 77.92%
Bonds
0.00% 0.00% 12.39% 81.76%

Stock Sector Breakdown

Weighting Return Low Return High FBIOX % Rank
Healthcare
100.00% 59.26% 100.00% 38.96%
Utilities
0.00% 0.00% 0.00% 77.92%
Technology
0.00% 0.00% 22.69% 80.52%
Real Estate
0.00% 0.00% 5.89% 79.22%
Industrials
0.00% 0.00% 7.02% 80.52%
Financial Services
0.00% 0.00% 1.60% 84.42%
Energy
0.00% 0.00% 0.00% 77.92%
Communication Services
0.00% 0.00% 9.11% 80.52%
Consumer Defense
0.00% 0.00% 25.73% 80.52%
Consumer Cyclical
0.00% 0.00% 1.92% 79.87%
Basic Materials
0.00% 0.00% 7.16% 86.36%

Stock Geographic Breakdown

Weighting Return Low Return High FBIOX % Rank
US
94.29% 66.06% 104.41% 52.20%
Non US
4.52% 0.00% 28.87% 41.51%

FBIOX - Expenses

Operational Fees

FBIOX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.66% 0.08% 4.48% 79.87%
Management Fee 0.65% 0.03% 1.25% 45.28%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

FBIOX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load N/A 1.00% 1.00% N/A

Trading Fees

FBIOX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 1.00% 95.12%

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

FBIOX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 46.00% 0.00% 238.00% 45.19%

FBIOX - Distributions

Dividend Yield Analysis

FBIOX Category Low Category High FBIOX % Rank
Dividend Yield 0.63% 0.00% 6.24% 27.67%

Dividend Distribution Analysis

FBIOX Category Low Category High Category Mod
Dividend Distribution Frequency SemiAnnual Annual Monthly Annual

Net Income Ratio Analysis

FBIOX Category Low Category High FBIOX % Rank
Net Income Ratio -0.14% -2.54% 1.85% 44.08%

Capital Gain Distribution Analysis

FBIOX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Semi-Annually Annually Annually Annually

Distributions History

View More +

FBIOX - Fund Manager Analysis

Managers

Rajiv Kaul


Start Date

Tenure

Tenure Rank

Oct 12, 2005

16.64

16.6%

Kaul is a portfolio manager with Fidelity Investments. Since joining Fidelity Investments in 1996, he has worked as a research analyst and portfolio manager. Kaul also manages another Fidelity fund. Prior to Fidelity, Kaul worked at Mckinsey & Company. He is the recipient of the Kann Rasmusson Environment Award, the Dean's Summer Research Award and a Ford Undergraduate Fellowship.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.02 24.72 7.88 0.25